NASDAQ:SILK Silk Road Medical - SILK Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. $51.21 -0.99 (-1.90%) (As of 02/8/2023 05:18 PM ET) Add Compare Share Share Today's Range$50.45▼$52.3850-Day Range$49.61▼$57.7952-Week Range$27.21▼$58.04Volume194,931 shsAverage Volume333,097 shsMarket Capitalization$1.95 billionP/E RatioN/ADividend YieldN/APrice Target$50.83 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Silk Road Medical MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside0.7% Downside$50.83 Price TargetShort InterestHealthy6.95% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment-0.17Based on 11 Articles This WeekInsider TradingSelling Shares$14.08 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.57) to ($1.39) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.50 out of 5 starsMedical Sector931st out of 1,026 stocksSurgical & Medical Instruments Industry97th out of 104 stocks 1.0 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $50.83, Silk Road Medical has a forecasted downside of 0.7% from its current price of $51.21.Amount of Analyst CoverageSilk Road Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted6.95% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in Silk Road Medical has recently decreased by 5.02%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 1.0 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Silk Road Medical this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for SILK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,077,744.00 in company stock.Percentage Held by InsidersOnly 7.66% of the stock of Silk Road Medical is held by insiders.Percentage Held by Institutions96.43% of the stock of Silk Road Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.57) to ($1.39) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -31.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -31.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 22.56. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Silk Road Medical (NASDAQ:SILK) StockSilk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.Read More Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Stock News HeadlinesFebruary 7, 2023 | finance.yahoo.comSilk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023February 7, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Lowered to Peer Perform at Wolfe ResearchFebruary 8, 2023 | RJO Futures (Ad)An All-In-One Guide for Trading MetalsSo many want to add metals to their portfolio. Metals can be a great way to protect your money and hedge against market downturns. But first, you need to know how. Download our FREE Guide to Metals Futures today from RJO Futures to get the information that you need to know to trade futures in metals. February 6, 2023 | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Insider Sells $364,999.65 in StockFebruary 4, 2023 | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Director Sells $715,440.00 in StockJanuary 23, 2023 | finance.yahoo.comWhat Makes Silk Road Medical (SILK) a New Strong Buy StockJanuary 9, 2023 | finance.yahoo.comSilk Road Medical, Inc: Reiterating BUY; raising target to $70December 30, 2022 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Q3 2022 Earnings Call TranscriptFebruary 8, 2023 | Tradewins (Ad)New Years, New Ways To Trade!If you’ve been considering options trading but don’t know where to start, trading champion Chuck Hughes’ coveted guide, “Options Trading Made Easy” is for you! Free for a limited time, this guide could help 2023 become your most profitable year yet! Click here for a free copy now! December 28, 2022 | finance.yahoo.comSilk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 22, 2022 | finance.yahoo.comIs Silk Road Medical (SILK) a Great Stock to Invest in?December 12, 2022 | finance.yahoo.comHere’s What Makes Silk Road Medical (SILK) a Strong StockDecember 5, 2022 | finance.yahoo.comSilk Road Medical (SILK) is a Great Momentum Stock: Should You Buy?December 3, 2022 | seekingalpha.comSilk Road Medical: Revise To Buy As TCAR Procedural Volume Ramps UpNovember 11, 2022 | seekingalpha.comSilk Road Medical, Inc. (SILK) Q3 2022 Earnings Call TranscriptNovember 10, 2022 | finance.yahoo.comSilk Road Medical Third Quarter 2022 Earnings: Beats ExpectationsNovember 9, 2022 | marketwatch.comSilk Road Shares Rise After 3Q Loss NarrowsNovember 8, 2022 | finance.yahoo.comSilk Road Medical Reports Third Quarter 2022 Financial ResultsNovember 8, 2022 | msn.comSilk Road Medical's Earnings: A PreviewNovember 4, 2022 | finance.yahoo.comSilk Road Medical to Present at Upcoming Investor ConferencesNovember 1, 2022 | finance.yahoo.comWill the Label Update Accelerate the Growth of Silk Road Medical (SILK)?October 25, 2022 | finance.yahoo.comSilk Road Medical to Report Third Quarter 2022 Financial Results on November 8, 2022October 20, 2022 | nasdaq.comSilk Road Medical Reaches Analyst Target PriceOctober 19, 2022 | nasdaq.comSilk Road Medical Climbs On Seeing Narrower Q3 LossOctober 19, 2022 | marketwatch.comSilk Road Medical Shares Up 9.5% After 3Q Revenue Growth ForecastOctober 19, 2022 | markets.businessinsider.comSilk Road Medical Prices Public Offering Of About 2.33 Mln Shares At $43.00/shrOctober 18, 2022 | finance.yahoo.comSilk Road Medical Announces Pricing of Public OfferingSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Company Calendar Last Earnings11/09/2021Today2/08/2023Next Earnings (Confirmed)2/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees352Year FoundedN/APrice Target and Rating Average Stock Price Forecast$50.83 High Stock Price Forecast$70.00 Low Stock Price Forecast$38.00 Forecasted Upside/Downside-0.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($1.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-49,810,000.00 Net Margins-45.16% Pretax Margin-45.01% Return on Equity-86.73% Return on Assets-36.66% Debt Debt-to-Equity Ratio1.30 Current Ratio6.14 Quick Ratio5.29 Sales & Book Value Annual Sales$101.47 million Price / Sales19.24 Cash FlowN/A Price / Cash FlowN/A Book Value$2.27 per share Price / Book22.56Miscellaneous Outstanding Shares38,120,000Free Float35,203,000Market Cap$1.95 billion OptionableNot Optionable Beta1.22 Key ExecutivesErica J. RogersPresident, Chief Executive Officer & DirectorLucas W. BuchananChief Financial & Operating OfficerSumaira MacdonaldExecutive Medical DirectorTammy LeitsingerVP-Professional Education & Medical AffairsRobert A. NicholasVice President-Operations & EngineeringKey CompetitorsAtriCureNASDAQ:ATRCGlaukosNYSE:GKOSNuVasiveNASDAQ:NUVAPROCEPT BioRoboticsNASDAQ:PRCTBeauty HealthNASDAQ:SKINView All CompetitorsInsiders & InstitutionsThrivent Financial for LutheransBought 17,785 shares on 2/8/2023Ownership: 1.104%Swiss National BankBought 1,800 shares on 2/8/2023Ownership: 0.223%Arizona State Retirement SystemBought 400 shares on 2/8/2023Ownership: 0.026%UBS Group AGBought 3,083 shares on 2/8/2023Ownership: 0.010%Arcadia Investment Management Corp MIBought 3,751 shares on 2/8/2023Ownership: 0.010%View All Insider TransactionsView All Institutional Transactions SILK Stock - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price forecast for 2023? 4 Wall Street analysts have issued 12-month price targets for Silk Road Medical's shares. Their SILK share price forecasts range from $38.00 to $70.00. On average, they expect the company's stock price to reach $50.83 in the next twelve months. This suggests that the stock has a possible downside of 0.7%. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2023? Silk Road Medical's stock was trading at $52.85 at the start of the year. Since then, SILK shares have decreased by 3.1% and is now trading at $51.21. View the best growth stocks for 2023 here. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) posted its earnings results on Tuesday, November, 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by $0.09. The company earned $24.70 million during the quarter, compared to analyst estimates of $26.03 million. Silk Road Medical had a negative trailing twelve-month return on equity of 86.73% and a negative net margin of 45.16%. During the same period in the previous year, the firm posted ($0.31) earnings per share. What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical issued an update on its FY 2022 earnings guidance on Thursday, December, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $134.00 million-$137.00 million, compared to the consensus revenue estimate of $130.60 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an IPO on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Thrivent Financial for Lutherans (1.10%), Allspring Global Investments Holdings LLC (0.91%), Peregrine Capital Management LLC (0.70%), Lisanti Capital Growth LLC (0.57%), Swiss National Bank (0.22%) and New York State Common Retirement Fund (0.20%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $51.21. How much money does Silk Road Medical make? Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.95 billion and generates $101.47 million in revenue each year. The company earns $-49,810,000.00 in net income (profit) each year or ($1.63) on an earnings per share basis. How many employees does Silk Road Medical have? The company employs 352 workers across the globe. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013. This page (NASDAQ:SILK) was last updated on 2/8/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.